HIV/AIDS and drug use in China--interactions, impacts, and issues.
The interrelationships of HIV/AIDS and drug use and misuse result in complex problems that have been addressed by a variety of sociolegal approaches that often are in contrast to evidence-based medical practices proven effective in reducing associated harms. Like other countries struggling to reduce the incidence and consequences of addiction and HIV/AIDS, China is working to improve systems of care and to revise policies toward drug use and misuse and HIV/AIDS. Greater interaction with researchers and clinicians from around the world can foster increased awareness of effective practices and help implement effective strategies to deal with the problems of HIV/AIDS, and addiction.
Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Min
M
Zhao
Walter
W
Ling
D000328:Adult; D002047:Buprenorphine / Q000627:therapeutic use; D002681:China / Q000453:epidemiology; D003695:Delivery of Health Care; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control*; D040261:Harm Reduction; D006801:Humans; D038622:Internationality; D008297:Male; D009292:Narcotic Antagonists / Q000627:therapeutic use; D058850:Opiate Substitution Treatment; D058996:Quality Improvement; D012309:Risk-Taking; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control / Q000534:rehabilitation
D009292:Narcotic Antagonists; D002047:Buprenorphine